Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $440,202 - $654,569
-4,700 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$116.57 - $155.01 $454,623 - $604,539
3,900 Added 487.5%
4,700 $619,000
Q4 2020

Feb 16, 2021

SELL
$99.61 - $142.12 $79,688 - $113,696
-800 Reduced 50.0%
800 $106,000
Q2 2020

Aug 14, 2020

SELL
$55.75 - $92.75 $111,500 - $185,500
-2,000 Reduced 55.56%
1,600 $139,000
Q3 2019

Nov 14, 2019

BUY
$90.37 - $122.49 $325,332 - $440,964
3,600 New
3,600 $325,000
Q2 2019

Aug 14, 2019

SELL
$89.51 - $118.04 $205,873 - $271,492
-2,300 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$61.98 - $96.5 $142,554 - $221,950
2,300 New
2,300 $199,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.1B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.